Insmed Incorporated (1INSM)
MTA
103.80
0.00 (0.00%)
Closed
Oct 2, 2026
Day's Range
103.80103.80
52 wk Range
79.25179.00
Financial Statements - 1INSM - Insmed Incorporated
Revenue
606.42M▲ 96.8%
Net Income
-1.27B▼ 65.0%Net Margin -210.5%
EBITDA
-986.38M▼ 49.3%
Free Cash Flow
-967.57M▼ 61.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 606.42M | 308.08M |
| Cost of Goods | 122.93M | 72.62M |
| Gross Profit | 483.48M | 235.45M |
 Operating Expense | - | - |
| Operating Income | -994.77M | -666.27M |
| Non-Operating Interest | - | - |
| Other Income Expense | -193.17M | -32.68M |
| Pre Tax Income | -1.27B | -770.87M |
| Income Tax | 5.02M | 3.14M |
| Net Income | -1.27B | -774.01M |
| EPS Basic | -6.42 | -5.57 |
| EPS Diluted | -6.42 | -5.57 |
| Basic Shares Outstanding | 199.01M | 138.95M |
| Diluted Shares Outstanding | 199.01M | 138.95M |
| Ebit | -1.19B | -702.89M |
| Ebitda | -986.38M | -660.86M |
| Net Income Continuous Operations | -1.27B | -774.01M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
